His guilty plea came after multiple pre-trial conferences and court adjournments since he was charged in October 2024. Read ...

SINGAPORE: Property tycoon Ong Beng Seng pleaded guilty on Aug 4 to abetting the obstruction of justice in a case linked to ...

By the time the scan is done, the disease may already have advanced. A cancer that could have been caught in time slowly ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, ...

Building on bispecific antibodies, four of which have been approved by the FDA to treat relapsed/refractory multiple myeloma, ...

Panelists discuss how recent updates from the phase 3 IsKia trial demonstrate that isatuximab combined with carfilzomib, lenalidomide, and dexamethasone improves minimal residual disease negativity ...

AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a ...

Researchers at Uppsala University have identified a promising therapeutic approach for the challenging blood cancer multiple myeloma.

The FDA’s approval of linvoseltamab for adults with heavily pretreated relapsed/refractory multiple myeloma marks a significant advance, with Sundar Jagannath, MBBS, emphasizing its high response ...

GlaxoSmithKline (GSK) is conducting a Phase 3 clinical study titled A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help patients suffering.